Seby John
Research Subjects
Seby John has a total of 867 co-authors. Here are the top co-authors by number of shared publications:
- Praveen Kesav
Department of Neurology, Neurological Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates
10 shared publications Syed Irteza Hussain
Department of Neurology and Neurointerventional Surgery, Neurological Institute (NI), Cleveland Clinic Abu Dhabi (CCAD), Abu Dhabi, UAE
9 shared publicationsPraveen Kesav
Department of Neurology, Neurological Institute, Cleveland Clinic Abu Dhabi, United Arab Emirates
5 shared publications- Syed Irteza Hussain
Neurological Institute Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates
5 shared publications - Ossama Yassin Mansour
Alexandria University
4 shared publications - Syed Irteza Hussain
From the Departments of Neurology (P.K., A.J.), Neurology and Neurointerventional Surgery (S.I.H., S.J.), Neurological Institute, and Department of Neuroradiology (Z.S.), Imaging Sciences and Interventional Radiology Institute, Cleveland Clinic Abu Dhabi, UAE
4 shared publications
Latest Publications
- 25 October 2025
- Published by Springer Nature in Neuroradiology
- Vol. 67 (12) , 3363-3376
Real-World outcomes of thrombectomy for distal medium vessel occlusions in the middle East and North Africa region: A multicenter registry analysis
Purpose Recent randomized trials showed neutral results for distal medium vessel occlusion (DMVO) thrombectomy, but real-world effectiveness across diverse healthcare settings remains unknown. We evaluated DMVO thrombectomy outcomes in the Middle East and North Africa (MENA) region. Methods The MEMENTO registry retrospectively analyzed consecutive DMVO thrombectomy patients (M2, M3, A2-3, P2-3 segments) across 15 centers (2022–2024). DMVOs were classified as primary, baseline secondary, or iatrogenic secondary. Primary outcome was 90-day functional independence (mRS 0–2). Secondary outcomes included successful recanalization (TICI ≥ 2b), mortality, and symptomatic hemorrhage. Results Among 164 patients (median age 72, NIHSS 10), subtypes included primary (25%), baseline secondary (50%), and iatrogenic secondary (25%) DMVOs. Overall successful recanalization was 69%, with primary DMVOs achieving higher rates than baseline secondary (78% vs. 59%, p = 0.046). Good functional outcome occurred in 54% overall, with no significant differences between subtypes (primary 59%, baseline secondary 51%, iatrogenic secondary 54%, p = 0.661). Stent retriever achieved highest recanalization (85%) followed by combination (74%) and aspiration (45%, p = 0.046). Independent predictors of poor outcome included age > 75 (aOR 2.34, 95% CI 1.18–4.64), NIHSS > 15 (aOR 3.12, 95% CI 1.45–6.71), and unsuccessful recanalization (aOR 4.89, 95% CI 2.31–10.35). Cost-effectiveness analysis across MENA income levels yielded ICERs of $26,875-$71,333/QALY, exceeding regional GDP thresholds. The modest numerical difference in outcomes (54% vs. 45% historical controls) does not establish clinical benefit given neutral randomized trial results. Conclusions Real-world DMVO thrombectomy outcomes closely mirror recent randomized trial results showing limited clinical benefit compared to medical management across diverse healthcare settings, with prohibitive economic costs that challenge routine implementation. These findings support highly selective application focusing on younger patients with moderate deficits and primary occlusions.
- 25 October 2025
- Published by Springer Nature in Neuroradiology
- Vol. 67 (12) , 3363-3376
Real-World outcomes of thrombectomy for distal medium vessel occlusions in the middle East and North Africa region: A multicenter registry analysis
Purpose Recent randomized trials showed neutral results for distal medium vessel occlusion (DMVO) thrombectomy, but real-world effectiveness across diverse healthcare settings remains unknown. We evaluated DMVO thrombectomy outcomes in the Middle East and North Africa (MENA) region. Methods The MEMENTO registry retrospectively analyzed consecutive DMVO thrombectomy patients (M2, M3, A2-3, P2-3 segments) across 15 centers (2022–2024). DMVOs were classified as primary, baseline secondary, or iatrogenic secondary. Primary outcome was 90-day functional independence (mRS 0–2). Secondary outcomes included successful recanalization (TICI ≥ 2b), mortality, and symptomatic hemorrhage. Results Among 164 patients (median age 72, NIHSS 10), subtypes included primary (25%), baseline secondary (50%), and iatrogenic secondary (25%) DMVOs. Overall successful recanalization was 69%, with primary DMVOs achieving higher rates than baseline secondary (78% vs. 59%, p = 0.046). Good functional outcome occurred in 54% overall, with no significant differences between subtypes (primary 59%, baseline secondary 51%, iatrogenic secondary 54%, p = 0.661). Stent retriever achieved highest recanalization (85%) followed by combination (74%) and aspiration (45%, p = 0.046). Independent predictors of poor outcome included age > 75 (aOR 2.34, 95% CI 1.18–4.64), NIHSS > 15 (aOR 3.12, 95% CI 1.45–6.71), and unsuccessful recanalization (aOR 4.89, 95% CI 2.31–10.35). Cost-effectiveness analysis across MENA income levels yielded ICERs of $26,875-$71,333/QALY, exceeding regional GDP thresholds. The modest numerical difference in outcomes (54% vs. 45% historical controls) does not establish clinical benefit given neutral randomized trial results. Conclusions Real-world DMVO thrombectomy outcomes closely mirror recent randomized trial results showing limited clinical benefit compared to medical management across diverse healthcare settings, with prohibitive economic costs that challenge routine implementation. These findings support highly selective application focusing on younger patients with moderate deficits and primary occlusions.
- 1 June 2025
- Published by Wolters Kluwer Health in Stroke
- Vol. 56 (6) , e155-e156
Spot Sign in Cerebral Venous Sinus Thromboses–Associated Intracerebral Hemorrhage
- 1 June 2025
- Published by Wolters Kluwer Health in Stroke
- Vol. 56 (6) , e155-e156
Spot Sign in Cerebral Venous Sinus Thromboses–Associated Intracerebral Hemorrhage
- Open Access
- 4 October 2024
- Published by Wolters Kluwer Health in Annals of Indian Academy of Neurology
- Vol. 28 (1) , 131-132
An Atypical Presentation of Vascular Eagle Syndrome
An abstract is unavailable. This article is available as a PDF only.
- 4 October 2024
- Published by Wolters Kluwer Health in Annals of Indian Academy of Neurology
- Vol. 28 (1) , 131-132
Open AccessAn Atypical Presentation of Vascular Eagle Syndrome
An abstract is unavailable. This article is available as a PDF only.
- Open Access
- 1 October 2024
- Published by Taylor & Francis in Vascular Health and Risk Management
- Vol. ume 20, 453-465
Primary CNS Vasculitis - A Focussed Review on Treatment
Primary central nervous system vasculitis (PCNSV) is a rare and complex disease that poses formidable diagnostic and therapeutic challenges. Since its initial recognition as a distinct clinical entity in the 1950s, there has been considerable advancement in our understanding of PCNSV histopathology, specific clinical subsets, and their response to treatment. However, PCNSV is one of the rarest vasculitides, and still remains a challenging diagnosis with many unanswered questions regarding optimal management. In this review, we intend to provide a detailed outline of approaches that are currently being employed for the treatment of PCNSV. We exhaustively review available cohort series of PCNSV and critically appraise the data for study definitions, treatment approaches, and predictors of treatment outcomes. Finally, we also propose a treatment approach for PCNSV.
- 1 October 2024
- Published by Taylor & Francis in Vascular Health and Risk Management
- Vol. ume 20, 453-465
Open AccessPrimary CNS Vasculitis - A Focussed Review on Treatment
Primary central nervous system vasculitis (PCNSV) is a rare and complex disease that poses formidable diagnostic and therapeutic challenges. Since its initial recognition as a distinct clinical entity in the 1950s, there has been considerable advancement in our understanding of PCNSV histopathology, specific clinical subsets, and their response to treatment. However, PCNSV is one of the rarest vasculitides, and still remains a challenging diagnosis with many unanswered questions regarding optimal management. In this review, we intend to provide a detailed outline of approaches that are currently being employed for the treatment of PCNSV. We exhaustively review available cohort series of PCNSV and critically appraise the data for study definitions, treatment approaches, and predictors of treatment outcomes. Finally, we also propose a treatment approach for PCNSV.
- Open Access
- 30 September 2024
- Published by Korean Society of Cerebrovascular Surgeons/Korean Society of Endovascular Surgery in Journal of Cerebrovascular and Endovascular Neurosurgery
- Vol. 26 (3) , 324-330
Primary Angiitis of Central Nervous System related intracranial aneurysm with spontaneous occlusion after immunomodulatory treatment
Primary Angiitis of the Central Nervous System (PACNS) is an uncommon disease with kaleidoscopic clinical manifestations. Ischemic strokes are commoner than their hemorrhagic counterpart. Intracranial pseudoaneurysms are rarely reported in PACNS cohorts. We hereby describe the case of a 39-year-old female, who presented for evaluation of acute onset of left middle cerebral artery (MCA) ischemic stroke, with cerebral angiogram showing multifocal stenosis and irregularities in intracranial blood vessels with an aneurysm arising from the lenticulostriate branch of the left MCA M1 segment. A diagnosis of probable PACNS was made and patient initiated on immunomodulatory treatment with corticosteroids. 12 weeks follow up neuroimaging studies revealed resolution of the previously described intracranial aneurysm, thereby postulating the possibility of a pseudoaneurysm related to the underlying angiitis.
- 30 September 2024
- Published by Korean Society of Cerebrovascular Surgeons/Korean Society of Endovascular Surgery in Journal of Cerebrovascular and Endovascular Neurosurgery
- Vol. 26 (3) , 324-330
Open AccessPrimary Angiitis of Central Nervous System related intracranial aneurysm with spontaneous occlusion after immunomodulatory treatment
Primary Angiitis of the Central Nervous System (PACNS) is an uncommon disease with kaleidoscopic clinical manifestations. Ischemic strokes are commoner than their hemorrhagic counterpart. Intracranial pseudoaneurysms are rarely reported in PACNS cohorts. We hereby describe the case of a 39-year-old female, who presented for evaluation of acute onset of left middle cerebral artery (MCA) ischemic stroke, with cerebral angiogram showing multifocal stenosis and irregularities in intracranial blood vessels with an aneurysm arising from the lenticulostriate branch of the left MCA M1 segment. A diagnosis of probable PACNS was made and patient initiated on immunomodulatory treatment with corticosteroids. 12 weeks follow up neuroimaging studies revealed resolution of the previously described intracranial aneurysm, thereby postulating the possibility of a pseudoaneurysm related to the underlying angiitis.
- Open Access
- 31 March 2024
- Published by Korean Society of Cerebrovascular Surgeons/Korean Society of Endovascular Surgery in Journal of Cerebrovascular and Endovascular Neurosurgery
- Vol. 26 (1) , 79-84
Spontaneous occlusion of a pial arteriovenous fistula after angiography: The role of iodinated contrast media
Intracranial non-galenic pial arteriovenous fistula (PAVF) is an extremely rare vascular malformation, where one or more pial arteries feeds directly into a cortical vein without any intervening nidus. Though occasionally they can be asymptomatic, neurological symptoms such as headache, seizure, or focal neurological deficit are more common presenting features. Life threatening or fatal hemorrhage is not uncommon, hence needed to be treated more often than not. Spontaneous occlusion of PAVF is reported only four times before. We report a 49-year-old gentleman, who was diagnosed to have a PAVF, possibly secondary to trauma. He presented 5 months and 22 days from initial digital subtraction angiography (DSA) for treatment, and follow-up angiogram showed complete obliteration. He denied any significant event, medication or alternate treatment during this period. His clinical symptoms were stable as well. We postulate iodinated contrast medium induced vasculopathy as a possible cause, which has been described for other vascular pathologies, but never for PAVF.
- 31 March 2024
- Published by Korean Society of Cerebrovascular Surgeons/Korean Society of Endovascular Surgery in Journal of Cerebrovascular and Endovascular Neurosurgery
- Vol. 26 (1) , 79-84
Open AccessSpontaneous occlusion of a pial arteriovenous fistula after angiography: The role of iodinated contrast media
Intracranial non-galenic pial arteriovenous fistula (PAVF) is an extremely rare vascular malformation, where one or more pial arteries feeds directly into a cortical vein without any intervening nidus. Though occasionally they can be asymptomatic, neurological symptoms such as headache, seizure, or focal neurological deficit are more common presenting features. Life threatening or fatal hemorrhage is not uncommon, hence needed to be treated more often than not. Spontaneous occlusion of PAVF is reported only four times before. We report a 49-year-old gentleman, who was diagnosed to have a PAVF, possibly secondary to trauma. He presented 5 months and 22 days from initial digital subtraction angiography (DSA) for treatment, and follow-up angiogram showed complete obliteration. He denied any significant event, medication or alternate treatment during this period. His clinical symptoms were stable as well. We postulate iodinated contrast medium induced vasculopathy as a possible cause, which has been described for other vascular pathologies, but never for PAVF.
- 7 February 2024
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 239, 108167
Racial differences in P2Y12 inhibitor responsiveness in patients undergoing neuro-endovascular procedures: A cohort from the Middle East
- 7 February 2024
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 239, 108167
Racial differences in P2Y12 inhibitor responsiveness in patients undergoing neuro-endovascular procedures: A cohort from the Middle East
- Open Access
- 1 August 2023
- Published by Taylor & Francis in Vascular Health and Risk Management
- Vol. ume 19, 543-556
Cerebrovascular Fibromuscular Dysplasia – A Practical Review
Fibromuscular dysplasia (FMD) is a rare idiopathic, segmental, noninflammatory and nonatherosclerotic arteriopathy of medium-sized arteries. It is classically considered to be a disease of young and middle adulthood, with females more commonly affected than males. FMD is a systemic disease. Although historically considered to be rare, cerebrovascular FMD (C-FMD) has now been recognized to be as common as the renovascular counterpart. Extracranial carotid and vertebral arteries are the most commonly involved vascular territories in C-FMD with the clinical presentation determined by vessels affected. Common symptoms include headaches and pulsatile tinnitus, with transient ischemic attacks, ischemic stroke and subarachnoid or intracerebral hemorrhage constituting the more severe clinical manifestations. Cervical artery dissection involving carotids more often than vertebral arteries and intracranial aneurysms account for the cerebrovascular pathologies detected in C-FMD. Our understanding regarding C-FMD has been augmented in the recent past on account of dedicated C-FMD data from North American, European and other international FMD cohorts. In this review article, we provide an updated and comprehensive overview on epidemiology, clinical presentation, etiology, diagnosis and management of C-FMD.
- 1 August 2023
- Published by Taylor & Francis in Vascular Health and Risk Management
- Vol. ume 19, 543-556
Open AccessCerebrovascular Fibromuscular Dysplasia – A Practical Review
Fibromuscular dysplasia (FMD) is a rare idiopathic, segmental, noninflammatory and nonatherosclerotic arteriopathy of medium-sized arteries. It is classically considered to be a disease of young and middle adulthood, with females more commonly affected than males. FMD is a systemic disease. Although historically considered to be rare, cerebrovascular FMD (C-FMD) has now been recognized to be as common as the renovascular counterpart. Extracranial carotid and vertebral arteries are the most commonly involved vascular territories in C-FMD with the clinical presentation determined by vessels affected. Common symptoms include headaches and pulsatile tinnitus, with transient ischemic attacks, ischemic stroke and subarachnoid or intracerebral hemorrhage constituting the more severe clinical manifestations. Cervical artery dissection involving carotids more often than vertebral arteries and intracranial aneurysms account for the cerebrovascular pathologies detected in C-FMD. Our understanding regarding C-FMD has been augmented in the recent past on account of dedicated C-FMD data from North American, European and other international FMD cohorts. In this review article, we provide an updated and comprehensive overview on epidemiology, clinical presentation, etiology, diagnosis and management of C-FMD.
- 17 March 2023
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 227, 107681
Editorial
- 7 March 2023
- Published by Wolters Kluwer Health in Neurology
- Vol. 100 (10) , 490-491
Teaching NeuroImage: Reinhold Hemimedullary Syndrome
- 7 March 2023
- Published by Wolters Kluwer Health in Neurology
- Vol. 100 (10) , 490-491
Teaching NeuroImage: Reinhold Hemimedullary Syndrome